We do not have data on specific medications that participants were receiving; however, published data from AWI-Gen has shown that hypertension awareness, treatment, and control are poor in this cohort22 and therefore the effect of any angiotensin-converting-enzyme inhibitors is likely to be low. This evidence concerns the gene ACE and Hypertension.